Back to Search
Start Over
The isocitrate dehydrogenase 1 is a potential prognostic indicator for non-small cell lung cancer patients
- Source :
- The International journal of biological markers. 36(4)
- Publication Year :
- 2021
-
Abstract
- Background The serum isocitrate dehydrogenase 1(IDH1) level is significantly elevated in patients with non-small cell lung cancer (NSCLC) and has important clinical value as a marker for early diagnosis. This study examined the dynamic changes of serum IDH1 levels of patients with NSCLC undergoing surgery or medical treatment, to evaluate its potential prognostic value. Methods The study cohort included 83 NSCLC patients who underwent surgery, 37 NSCLC patients who underwent medical treatment, 50 healthy controls, and 52 disease controls. Serum levels of IDH1 were assayed by enzyme-linked immunoassay. Tumor biomarkers including carcinoembryonic antigen, squamous cell carcinoma, neuron-specific enolase, CYFRA21-1, and pro-gastrin-releasing peptide—which are currently used in clinical practice—were measured by automatic immunoanalyzers. Results Serum IDH1 was significantly higher in patients with NSCLC compared with healthy people or patients with benign lung diseases ( p < 0.001). The area under the receiver operating characteristic curve for diagnosis and differential diagnosis were 0.897 and 0.879, respectively, which were superior to the five tumor markers. Serum IDH1 levels decreased in most patients after surgery, with the most dramatic changes in patients with stage I tumors compared with stage II and III. Analyses of changes in the serum IDH1 level of patients after receiving chemotherapy or targeted therapy revealed that for patients with progressive disease, serum IDH1 increased significantly after treatment; for patients with partial response or stable disease, it decreased steadily. Conclusion IDH1 has potential prognostic value and may be used as a marker for the monitoring of treatment efficacy.
- Subjects :
- Cancer Research
medicine.medical_specialty
IDH1
Lung Neoplasms
medicine.medical_treatment
Clinical Biochemistry
Gastroenterology
Pathology and Forensic Medicine
Targeted therapy
Carcinoembryonic antigen
Antigens, Neoplasm
Internal medicine
Carcinoma, Non-Small-Cell Lung
Biomarkers, Tumor
Medicine
Humans
Lung cancer
Keratin-19
Chemotherapy
biology
business.industry
medicine.disease
Prognosis
Isocitrate Dehydrogenase
Carcinoembryonic Antigen
Isocitrate dehydrogenase
Oncology
biology.protein
Differential diagnosis
business
Progressive disease
Subjects
Details
- ISSN :
- 17246008
- Volume :
- 36
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- The International journal of biological markers
- Accession number :
- edsair.doi.dedup.....983d682f9b9d862f766cb3879752b742